The biotech industry is experiencing a rush of AI-powered tools for many aspects of the complex drug discovery process. But one that has flown under the radar, increasingly thought to be key to certain diseases but woefully understudied, is RNA. With $35 million in new funding, Atomic AI aims to do for RNA what AlphaFold […]
With new funding, Atomic AI envisions RNA as the next frontier in drug discovery by Devin Coldewey originally published on TechCrunch...